Triple antithrombotic therapy
007
Approved small_molecule active
Quick answer
Triple antithrombotic therapy for Acute Coronary Syndrome (ACS) is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Acute Coronary Syndrome (ACS)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active